Kentucky
General Assembly

02/16/23	introduced in House to Committee on Committees (H)
02/23/23	to Judiciary (H)
03/01/23	reported favorably, 1st reading, to Calendar with Committee Substitute (1)
03/02/23	2nd reading, to Rules posted for passage in the Regular Orders of the Day for Friday, March 03, 2023
03/08/23	3rd reading, passed 93-0 with Committee Substitute (1)
03/09/23	received in Senate to Committee on Committees (S)
03/13/23	taken from Committee on Committees (S) 1st reading returned to Committee on Committees (S) to Health Services (S)
03/14/23	taken from Health Services (S) 2nd reading returned to Health Services (S)
03/29/23	reported favorably, to Rules with Committee Substitute (1) and Committee Amendment (1-title) as a consent bill
03/30/23	posted for passage in the Consent Orders of the Day for Thursday, March 30, 2023 3rd reading, passed 37-0 with Committee Substitute (1) and Committee Amendment (1-title) received in House to Rules (H) posted for passage for concurrence in Senate Committee Substitute (1) and Committee Amendment (1-title) House concurred in Senate Committee Substitute (1) and Committee Amendment (1-title) passed 96-0 enrolled, signed by Speaker of the House enrolled, signed by President of the Senate delivered to Governor
03/31/23	signed by Governor (Acts Ch. 166)

Amendment	House Committee Substitute 1
Summary	Retain original provisions, except delete the amendments to the definition of "fentanyl" in KRS 218A.010; further amend KRS 218A.500 to exclude testing equipment used to determine the presence of a synthetic opioid or its analogues in controlled substances from the prohibition of possession of drug paraphernalia; provide exceptions.
Index Headings	Crimes and Punishments - Drug paraphernalia, drug testing equipment, fentanyl or fentanyl analogue Drugs and Medicines - Drug paraphernalia, drug testing equipment, fentanyl or fentanyl analogue Opioids - Drug paraphernalia, drug testing equipment, fentanyl or fentanyl analogue Substance Abuse - Drug paraphernalia, drug testing equipment, fentanyl or fentanyl analogue

Amendment	Senate Committee Substitute 1
Summary	Amend KRS 218A.500 to exclude testing equipment used to determine the presence of a synthetic opioid or its analogues in controlled substances from the prohibition of possession of drug paraphernalia; provide exceptions; amend KRS 533.282, relating to the behavioral health conditional dismissal program, to establish that program services may be performed by the program provider directly or in conjunction with other treatment providers; establish additional accreditation methods for treatment providers and recovery housing service providers; amend KRS 533.288 to add the executive director of the Office of Adult Education as a member of the Behavioral Health Conditional Dismissal Program Implementation Council; direct the Cabinet for Health and Family Services to conduct a Fentanyl Education and Awareness campaign.
Index Headings	Crimes and Punishments - Drug paraphernalia, drug testing equipment, fentanyl or fentanyl analogue Drugs and Medicines - Drug paraphernalia, drug testing equipment, fentanyl or fentanyl analogue Health and Medical Services - Pilot program, behavioral health disorder, treatment providers Advisory Boards, Commissions, and Committees - Pilot program, behavioral health disorder, implementation council, member addition Opioids - Drug paraphernalia, drug testing equipment, fentanyl or fentanyl analogue Opioids - Pilot program, behavioral health disorder, recovery housing, facility eligibility Opioids - Pilot program, behavioral health disorder, treatment providers Substance Abuse - Drug paraphernalia, drug testing equipment, fentanyl or fentanyl analogue

Amendment	Senate Committee Amendment 1
Sponsor	S. Meredith
Summary	Make title amendment.
Index Headings	Title Amendments - HB 353/GA